Crism Therapeutics Corporation Director Dealing
June 03 2024 - 10:25AM
RNS Regulatory News
RNS Number : 9176Q
Crism Therapeutics Corporation
03 June 2024
3 June 2024
CRISM Therapeutics
Corporation
(AIM:CRTX)
Director
Dealing
CRISM Therapeutics Corporation
("CRISM" or the "Company") announces that it has been notified that
Non-Executive Director, Gerald Beaney has purchased 25,000 ordinary
shares of the Company at a price of 9.265 pence per
share.
Following this purchase, Mr Beaney
holds 25,000 ordinary shares, which represents approximately 0.08%
of the Company's total issued share capital of 32,678,312.
Enquiries:
|
Company
|
Nomad and
Broker
|
Financial
PR
|
|
CRISM Therapeutics
Corporation
|
S.P. Angel Corporate Finance
LLP
|
Buchanan
|
|
Andrew
Webb, CEO
Chris
McConville, CSO
|
Richard
Morrison
Adam
Cowl
|
Mark
Court mark.court@buchanancomms.co.uk
Jamie
Hooper jamie.hooper@buchanancomms.co.uk
|
|
via
Buchanan
|
+44 (0)
20 3470 0470
|
+44 (0)
20 7466 5000
|
Dealings by Persons Discharging Managerial
Responsibilities
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Gerald Beaney
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial
Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
CRISM Therapeutics
Corporation
|
|
b)
|
LEI
|
213800XFW6MKVCHHPW88
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
|
Ordinary shares with no par
value
|
|
|
|
|
Identification code
|
ISIN: VGG042401262
|
|
|
|
|
b)
|
Nature of the transaction
|
Purchase of shares
|
|
c)
|
Price(s) and volume(s)
|
|
|
Director/PDMR
|
Price
|
Volume
|
|
Gerald Beaney
|
9.265
|
25,000
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
|
|
- Aggregated volume
|
25,000
|
|
|
|
|
- Price
|
£2,316.25
|
|
|
|
|
e)
|
Date of the transaction
|
3 June 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHFLFFSRSIVIIS
Crism Therapeutics (LSE:CRTX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Crism Therapeutics (LSE:CRTX)
Historical Stock Chart
From Nov 2023 to Nov 2024
